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Oxidative stress can be considered a consequence of
imbalance in the formation of reactive oxygen species
(ROS) and antioxidant defense systems, in which mitochon-
dria appear to be the main source of ROS production. A key
concern is that high levels of ROS can modulate molecular
and structural modifications and lead to functional changes
within the muscle. In this regard, ROS causes oxidation of
biomolecules, in which results in loss of their biological
functions and leads to homeostatic imbalance. The main
effects mediated by ROS relate to its potential to cause oxida-
tive damage in cells and tissues [1]. Therefore, a ROS burst
contributes to cellular dysfunction and can cause a wide
range of chronic diseases. Scientific advances have allowed
a better understanding of the role of oxidative stress on mus-
cular homeostasis; thereby, deciphering and understanding
how ROS regulate specific molecules and processes that alter
physiological function could cause development of patholo-
gies. Thus, studying the effects of ROS could assist with the
development of new therapeutic avenues that address a wide
range of muscle disorders.
This special issue encompasses cutting-edge research and
review articles that focus on the role of oxidative stress in
both acute and chronic progressive muscle disorders. This
special issue provides a platform for sharing recent scientific
advancements with researchers and practitioners who work
in both skeletal and cardiac muscle scopes, which include
clinical diagnostics, basic scientists, and physicians interested
in physiology and physiopathology of muscle. Thus, articles
included in this special issue address the molecular and
cellular mechanisms involved in these processes as well as
current therapeutic approaches in human and animals.
Two investigations in this special issue focus on physio-
logical changes induced by acute exercise and subsequent
oxidative stress in male runners who completed a marathon
race in two different thermal conditions—hot and temperate
environments, as well as a rat model of resistance exercise. In
these studies, marathon running performance decreased up
to 10%, while the wet bulb globe temperature increased from
10 to 25°C [2]. The investigation also highlighted that hot
temperature induces pronounced homeostatic alterations,
including a proinflammatory response, limited muscle
oxygenation, and increased oxidative stress [3, 4]. In the study
by H. A. de Oliveira et al., male marathon runners were stud-
ied to determine the effects of environmental temperature
variation on hematological profiles; tissue damage and oxida-
tive stress markers were investigated in men. The perfor-
mance of marathon runners was reduced 13.5% in a hot
environment (31.4°C) compared when they were performing
at a lower temperature (19.8°C). In both environments, mara-
thon racing promotes fluid and electrolyte imbalances, hemo-
lysis, immune activation, tissue damage, and oxidative stress.
Moreover, long-term exercise during heat stress conditions
worsened running performance by causing hematological
changes due to fluid and electrolyte imbalances and purine/
protein oxidation of erythrocytes, which lead to renal damage
and immune activation. On the other hand, the authors have
concluded that reduced performance at hot environment is
not associated with muscle damage and lipid peroxidation.
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Exercise-induced increases in free radical formation are
thought to play a key role in the mechanisms by which skel-
etal muscle adapts to exercise training [5, 6], whereas aerobic
physical exercise appears to be the main trigger of free radical
formation. In addition, resistance exercise can also evoke
increased free radical production in muscle because of the
occurrence of intermittent bouts of hypoxia/reperfusion.
An excessive increase in oxidative stress or a free radical burst
in working muscles can override the physiological benefits of
exercise causing extensive damage to proteins and cellular
dysfunction [7, 8]. This is a key concern during intense
training stages, in which the burst in free radicals can
overcome the existing antioxidant mechanisms. In fact, stud-
ies have reported beneficial effects of antioxidant agents used
to counteract the increase in oxidative stress induced by
exercise. In this special issue, R. A. Oliveira et al. applied
low-intensity laser therapy in rat gastrocnemius muscle prior
to a high-intensity resistance exercise session. The laser
application brought about improvements in lipoperoxidation
levels and the oxidized protein content in muscle. Moreover,
laser therapy appeared to increase activity of antioxidant
enzymes (i.e., superoxide dismutase and glutathione peroxi-
dase) and led to higher total nonenzymatic antioxidant
potential. Thus, photobiomodulation could be a promising
antioxidant approach to counter risks associated with high-
intensity resistance exercises. However, further studies are
needed to better understand the influence of different irradi-
ation dosages and the mechanisms that modulate oxidative
stress linked to exercise.
Further analysis of the role of photobiomodulation was
showed in a review article entitled “Effects of Photobiomodu-
lation Therapy on Oxidative Stress in Muscle Injury Animal
Models: A Systematic Review,” which moves the focus on
from the several models of experimental muscle injury (e.g.,
fatigue, cryoinjury, and traumatic insult). First, S. A. dos
Santos et al. summarized that, despite the limited number
of studies in this research area, photobiomodulation could
be a factual approach to reduce oxidative stress markers
(e.g., thiobarbituric acid reactive) and to increase antioxidant
substances (e.g., superoxide dismutase, catalase, and gluta-
thione peroxidase). Second, the authors’ advocate “whole
mechanisms” by which photobiomodulation could modulate
oxidative stress generated during muscle injury. A possible
mechanism is the improvement of mitochondrial function,
which is associated with reduced free radical formation
linked to superoxide dismutase, catalase, and glutathione
peroxidase. The primary beneficial effect of photobiomodu-
lation in different muscles may be its anti-inflammatory
effects [9, 10]. In this regard, S. A. dos Santos et al. have
considered that oxidative muscular homeostasis linked to
photobiomodulation may be mediated by its anti-
inflammatory action, which mitigates the migration of
inflammatory cells (e.g., neutrophils and macrophages) and
thus the source of ROS.
This special issue also covers the role of oxidative stress
and antioxidants in different disorders using human cells
andmodel organisms. A. J. O’Leary et al. explored the cellular
and functional consequences of sustained hypoxic stress in a
mouse model of acute hypoxia and the effects of N-acetyl
cysteine (NAC) pretreatment. The authors showed that acute
hypoxic stress increases the protein content of HIF-1α in the
diaphragm as well as activated MAPK, mTOR, Akt, and
FoxO3a signaling pathways. Acute hypoxic stress also led to
increases in lipid peroxidation and FoxO3 and MuRF-56 1
gene expression in the diaphragm. The treatment with
NAC at a dose of 200mg/kg completely prevented
hypoxia-induced diaphragm dysfunction in mouse models
studied. NAC substantially enhanced cell survival signaling
pathways which, along with its general antioxidant func-
tions, prevented hypoxia-induced diaphragm oxidative
stress. These findings may have relevance to develop treat-
ment strategies for hypoxaemic respiratory patients and
populations living at high altitudes. NAC treatment was
also evaluated in a study conducted by A. Michelucci
et al., in which RYR1Y522S/WT knock-in mouse, carrying
a human mutation in RYR1 linked to malignant hyperther-
mia (MH) exhibiting cores with a NAC treatment regimen
for either two or six months. They found that two months
of NAC-treatment initiated at two months of age, when
mitochondrial and fiber damage was still minimal, (i)
reduced the formation of unstructured and contracture cores,
(ii) improved muscle function, (iii) and decreased mitochon-
drial damage. The beneficial effects of NAC treatment was
also evident following six months of treatment that was
initiated later, at four months of age when structural dam-
age was advanced. Likely, NAC exerts its protective effects
by lowering oxidative stress, as supported by the reduction
of 3-NT and Mn-superoxide dismutase levels. This work
suggests that NAC-administration is beneficial and
prevents mitochondrial damage and the formation of cores
and improves muscle function in RYR1Y522S/WT mice. S. C.
Khor et al. evaluated the effects of a 24 h treatment with
the antioxidant tocotrienol-rich fraction (TRF), with the
goal of reestablishing the oxidative status of myoblasts
during replicative senescence. The effects of TRF on oxida-
tive status were compared to the effects of other antioxi-
dants (α-tocopherol (ATF) and NAC). Treatment with
TRF was associated with diminished ROS production
and lipid peroxidation in senescent myoblasts. Moreover,
gene expression in senescent myoblasts of Mn-superoxide
dismutase, catalase, and glutathione peroxidase was modu-
lated by TRF. Additional parameters were affected by TRF
including increased activity of superoxide dismutase and
catalase and reduced glutathione peroxidase in senescent
myoblasts. In comparison to ATF and NAC, TRF was
more efficient at increasing antioxidant capacity and
reducing insult caused by free radicals. The authors sug-
gested that TRF can ameliorate antioxidant mechanisms
and improve replicative senescence-associated oxidative
stress in myoblasts.
An imbalance between oxidant and antioxidant systems
has been proposed as a secondary effect in Duchenne
muscular dystrophy (DMD, X-linked genetic disease). In this
regard, the significance and precise extent of the perturbation
in redox signaling cascades are poorly understood. L. Pelosi
et al. tried to fill this gap of knowledge. The authors reported
that mdx dystrophic mice can trigger a compensatory antiox-
idant response at the presymptomatic stage of the disease. On
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the other hand, increased circulating levels of IL-6 perturb
the redox signaling cascade, even prior to the development
of necrosis, which is responsible for the severity and
progressive nature of DMD disease. Multiple cellular and
molecular mechanisms have been implicated in the DMD,
which makes the disease complex to study and complicates
the development of beneficial interventions. In this regard,
M. D’Agostino et al. showed that miR-200c overexpression
impaired skeletal muscle differentiation in cultured myo-
blasts and anti-miR-200c treatment ameliorated myogenic
differentiation. Moreover, the authors found that miR-
200c and p66Shc Ser-36 phosphorylation was increased
in mdx muscles. These findings link miR-200c to muscle
wasting in DMD, in which miR-200c overexpression can
be evoked by ROS.
Accumulation of reactive oxygen species (ROS) can be
mitigated by inbuilt mechanisms that help prevent exces-
sive oxidative stress in cardiomyocytes during hypoxia-
reoxygenation. Nitric oxide (NO) can compete successfully
with oxygen when the myocardium experiences hypoxia.
Therefore, NO accumulation can serve in a protective role
by forming NO-Fe2+ complexes when chelating iron is
released from oxygen complexes [11]. The study by V. I.
Kapelko et al. explored the use of a stable NO donor (Oxa-
com®) (DNIC) dinitrosyle iron complex with glutathione to
preserve the integrity of cardiomyocytes and improve func-
tional outcomes in rat hearts after hypoxia-reoxygenation.
This study is the first to report antihypoxic cardioprotective
potential of Oxacom to counter hypoxic insult, including a
reduction in hypoxic contractures, attenuation of cardiac
arrhythmias, and an increase of left ventricular pressures
during reoxygenation. Oxacom pretreatment substantially
reduced ROS accumulation in hypoxia-treated rat cardio-
myocytes. The reduction in ROS is expected to improve
the performance of ion transporters and regulatory proteins,
maintaining their thiol groups in a reduced state and
protected by reversible S-nitrosylation [12, 13]. Oxacom
eliminates slow sarcoplasmic Ca2+ removal as well as
delayed relaxation of cardiomyocytes. These findings dove-
tail well, with the overall view that primary Ca2+ removal
from the sarcoplasm by the energy-dependent ion
transporters/exchangers is slowed down in hypoxia since
high-energy phosphates and oxygen are depleted. Some of
the protective effects of Oxacommay be derived by its impact
on improving mitochondrial function. This will benefit con-
tractile processes overall, which have even greater energy
requirements. Overall, the authors conclude that Oxacom
positively affects energy production and utilization, which
may underlie its ability to prevent hypoxic contractures and
the rapid functional recovery seen during reoxygenation.
Mechanisms to protect against oxidative stress appear to
diverge between the different sexes. A study by A. Michelucci
et al. addresses the unexplained sex differences that underlie
vulnerability for developing malignant hyperthermia (MH),
which is influenced by oxidative status. MH is a lethal disor-
der in humans, triggered by halogenated/volatile anesthetics,
and caused by the release of excessive calcium in skeletal
muscle [14, 15]. Estrogens protect calsequestrin-1 (CASQ1)
knockout mice during lethal hyperthermic episodes, and
the mechanism of protection relies on a reduction of oxida-
tive stress in muscle. When male CASQ1-null mice are
exposed to conditions that resemble human MH (halothane
and heat), they experience a high incidence of mortality
[16]. To explore the role of sex hormones in development
of MH, A. Michelucci et al. treated male and female
CASQ1-null mice with Premarin (conjugated estrogens)
and Leuprolide (GnRH analog), respectively, for one month.
Their findings demonstrate that previously vulnerable
CASQ1-null males were largely protected from MH-
induced mortality by Premarin treatment prior to exposure
to halothane and heat, while CASQ1 females treated with
Leuprolide suffered higher mortality rates after losing the
protective effects of estrogen. To explore functional changes
in these mice due to the hormonal treatments, individual
muscles were exposed to temperature and caffeine. The sar-
coplasmic Ca2+ release was measured in single fibers and
levels of oxidative stress, and expression of the main redox
regulators was measured. In summary, Premarin treatment
in CASQ1-null males reduced muscle temperature and
caffeine sensitivity, normalized the release of Ca2+ from the
sarcoplasmic reticulum (SR), and reduced oxidative stress.
Overall, female mice appear to be protected by female
sex hormones from lethal hyperthermic episodes by reduc-
ing the amount of sarcoplasmic reticulum Ca2+ leak and
oxidative stress.
An epidemiological study by E. Brunelli et al. examined a
healthy population in Italy consisting of woman and man
volunteers to look for early indicators of major cardiovascu-
lar risk factors [17–19]. Blood plasma from individuals was
analyzed for prooxidant and antioxidant molecules. In high
cardiovascular risk categories, a significant depletion in total
plasma antioxidant barrier efficacy was found. As expected,
increasing age correlated with increased oxidative status. In
addition, individuals with metabolic disorders including
diabetes, obesity, and dyslipidemia displayed significant
depletion of the efficacy of total plasma antioxidant barrier.
Known risk factors, such as cholesterol imbalance, appear
to be the main element leading to depletion of total plasma-
antioxidant barrier efficacy. Furthermore, minimal increases
in both total serum cholesterol and total serum cholesterol/
HDL as well as hypertension and slight increases in systolic
blood pressure significantly increase oxidative status. In
summary, this study identifies a primary prevention target
and depletion of the antioxidant barrier, as the earliest detect-
able redox disturbance. This redox perturbation appears to
pinpoint the likelihood that an individual will develop
cardiovascular disease in the future due to overutilization of
antioxidant-directed mechanisms.
We hope that this special issue is successful in providing
new insights into the impact of oxidative stress in muscle on
different physiological and pathological disorders. The
findings presented here can be used to improve knowledge
and understanding of changes induced by exercise on oxida-
tive stress, in which low-intensity laser therapy is able to
modulate excessive oxidative stress after physical effort. We
also feel that this is an opportunity to report findings
concerning the role of N-acetyl cysteine in different in vitro
and in vivo models. Moreover, the editors considered the
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interdisciplinary nature of the papers included as necessary
to expand on concepts fundamental to basic research as well
as those important to applied science. As a result, papers
covering the effects of oxidative stress in Duchenne muscular
dystrophy, cardiomyocyte hypoxia-reoxygenation, malig-
nant hyperthermia, and cardiovascular risk were included.
Therefore, the readers of this special issue should find
information of interest, relevant to their respective area
of scientific investigations.
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